Our calling through the years
Cadila cares about changing the trajectory of health for all humanity. For us, this is a calling and not just a business. A calling, into which we have been steadily investing all our pioneering spirit, science, human ingenuity and knowledge for the past decades. Throughout the company’s history, we’ve been guided by the principles and personal example of our founder-chairman and his people-first approach.
1926
Founder Chairman - Indravadan Ambalal Modi 1926-2012
Born on February 18, 1926, in a small village in Bharuch, Indravadan Ambalal Modi was on a mission to attain Swaraj (self-dependence) in healthcare for India. His compassion for the poor ignited his dream to make medicines affordable for all.
1931
First Employee - Shilaben Indravadan Modi 1931-2016
Shilaben Modi, the first employee of Cadila Laboratories, was a perennial source of inspiration to her husband, I. A.Modi. Her concern for people's well-being led to the manufacture of Cadila Gripe, the first indigenously produced gripe water in India.
1951
Self-Made Entrepreneur
I.A. Modi was not deterred by his resource constraints, he would ride over 40 km daily on his bicycle to visit doctors. At the age of 25, he was a producer, manager, administrator, accountant and delivery man – all rolled into one.
1952
Cadila Laboratories
I.A. Modi's first step in the pharmaceutical world began with the establishment of Cadila Laboratories on March 13, 1952. One of the company's first products, Livirubra was a vitamin supplement in liquid form.
1967
First Factory
With the foundation of its first factory premises at Ghodasar, Cadila began a journey of unprecedented growth.
1970
Medicine Man of India
Committed to nation building, Shri I A Modi, worked tirelessly to coagulate the Indian pharmaceutical industry by championing the Indian Patents Act, 1970 and formulating the 1986 Drug Policy of the Govt. of India. His efforts to make necessary drugs available to the marginalized earned him the title of 'Medicine Man of India'.
1985
Beyond business
Long before Corporate Social Resposibility had become a business mandate, Shri I A Modi instituted Kaka-Ba Hospital as a homage to his cousin Budh, who died of typhoid due to lack of medical facilities. This multi-speciality charity hospital provides free healthcare to thousands of impoverished lives.
1995
A New Beginning
In 1995, Cadila Laboratories was restructured and rechristened as Cadila Pharmaceuticals.
1996
The Growth Story 1999-2006
Cadila’s manufacturing capabilities grew from strength to strength with its state-of-the-art facilities.
- Bulk drug manufacturing facility at Dholka, Ahmedabad
- Formulation facility at Samba, Jammu
- API facility at Ankleshwar, Ahmedabad
2004
Africa - Our Second Home
Cadila established Ethiopia’s first WHO-cGMP compliant plant in Addis Ababa. It soon became an epicentre of multi-fold growth and development for Africa through enhanced investments.
2004
Innovative Miracles
Cadila developed pioneering first-in-the-world innovations for the treatment of cardiovascular diseases, lung cancer and tuberculosis.
Polycap, Mycidac-C, Risorine, Rabeloc IV and Immuvac
2005
More than a Pharma Company
Spreading the message of universal wellness, Cadila has expanded by diversifying into a host of industries.
- 1982 Karnavati Engineering Ltd. - Pharmaceutical Machinery
- 1983 Vetnova - Veterinary solutions
- 1986 IRM Ltd. - Travel and hospitality
- 1992 CadiAgro - Tissue Culture
- 2009 CPL Biologicals Pvt. Ltd. - Vaccines and diagnostics
2012
Founder Chairman – Indravadan Ambalal Modi 1926-2012
Born on February 18, 1926, in a small village in Bharuch, Indravadan Ambalal Modi was on a mission to attain Swaraj (self-dependence) in healthcare for India. His compassion for the poor ignited his dream to make medicines affordable for all.
2013
Cadila Pharmaceuticals at ICAI 2013
Dr Rajiv Modi, CMD of one of the largest privately held multinational companies - Cadila Pharmaceuticals, presents the inaugural speech at ICAI - Gujarat ,2013.
2013
Inaugurates iamicon 2013
Dr Rajiv Modi, Chairman and Managing Director of Cadila Pharmaceuticals, inaugurates iamicon 2013 with a riveting speech
2015
CMD Cadila Pharmaceuticals, meets Congresswoman Tulsi Gabbard
Dr Rajiv Modi, CMD of Indian multinational pharmaceutical company Cadila Pharmaceuticals met Congresswoman Tulsi Gabbard, Washington DC as a part of the CII CEOs delegation.
2016
Cadila Pharmaceuticals at Copenhagen
A 15 member business delegation headed by Dr Rajiv Modi, mounted by Confederation of Indian Industries visited Copenhagen on May 4th 2016 as a part of ‘India in Denmark’ project.
2016
Bio Asia – KPMG in India CEO Conclave on “Make in India”
Dr Rajiv Modi attended the Bio Asia – KPMG in India CEO Conclave on “Make in India (Flavours of policy change) held at Hyderabad to discuss on the opportunities for driving the Indian industry’s growth agenda to achieve the title of the ‘manufacturing hub’ of the world.
2017
‘Electron Microscopic Facilities’ at IIT Guwahati.
Dr. Rajiv Modi, CMD, Cadila Pharmaceuticals Chairman, Board of Governors, IIT Guwahati, inaugurates the ‘Electron Microscopic Facilities’ at IIT Guwahati.
2017
St. Petersburg International Economic Forum 2017
Dr. Rajiv Modi, CMD, Cadila Pharmaceuticals Ltd was a part of the St. Petersburg International Economic Forum. As a part of the #MakeinIndia Lounge, he addressed the session on State of Jharkhand.
2018
Cadila’s Calcirol wins WorldStar Packaging Award
Cadila Pharmaceuticals’ Calcirol Softgels won WorldStar Packaging Award for its unique and innovative packaging.
2019
Agreement with Norway based Serca Pharmaceuticals
Cadila inks agreement with Norway based Serca Pharmaceuticals for better treatment of heart patients
2019
Cadila to be the Premium Partner of CII Partnership Summit
Cadila to be the premium partner of the much-anticipated summit that will see global leaders deliberate on economic policy and future trends
2020
Cadila Pharma Launches Anti Allergic Drug Bilastine in India
Cadila Pharmaceuticals Limited has announced the launch of Bilastine syrup (30 ml) and Bilastine tablets in the strength of 20mg. It is indicated that Bilastine, an antihistamine drug is used in the treatment of allergic rhinitis.
2021
Oxygen Plant Inaugurated at Kaka-Ba Hospital
CADILA PHARMA LAUNCHES PROJECT SAAHAS FOR A HOLISTIC PUBLIC HEALTHCARE MODEL IN HANSOT, GUJARAT OXYGEN PLANT INAUGURATED AT KAKA-BA HOSPITAL
2022
Cadila Launches Tarzed For Early-stage Breast Cancer
Cadila Pharmaceuticals has launched trastuzumab under the brand name Tarzed. It is a humanized monoclonal antibody and is recommended for HER2-positive early-stage breast cancer and metastatic breast cancer.
2022
‘Best Record Holders’ globally for it’s Social Cause Campaign against Tuberculosis
Cadila Pharmaceuticals was declared one of the ‘Best Record Holders’ amongst 100 record holders across the world for its campaign initiative towards the ‘end the global epidemic -TB’ by worldkings.org.
2023
ThRabis® Wins the ET Pharma World Awards for “Innovation Pharma of the Year”
Cadila Pharmaceuticals’ breakthrough three-dose rabies vaccine, ThRabis, has won the top honour at the prestigious India Pharma World Awards, warding off competition from formidable players in the pharma industry.
2023
CII recognized Cadila :‘Top 50 Innovative Companies in India’
Cadila Pharmaceuticals, a privately held pharmaceutical company, has achieved distinction at the esteemed CII Industrial Innovation Awards 2023.
2024
World’s First – Aqueous Vitamin D Injection for Vitamin D Deficiency
Cadila Pharmaceuticals, announces the launch of the world's first aqueous formulation of cholecalciferol, setting a new benchmark in the treatment of Vitamin D deficiency.
The Care Continues...
Over the decades, Cadila has conquered countless milestones and has established itself as an integrated pharmaceutical company with presence across the entire life sciences value chain. The company that started its operations in a three-room apartment has transcended to a global brand that is empowered by over 8000 employees who endeavour to spread wellness in a million ways.
5
Continents
100+
Countries
45
Therapeutic Areas
